Leptospirosis-associated acute kidney injury: Penicillin at the late stage is still controversial

Journal of Clinical Pharmacy and Therapeutics

Volumn 37, Issue 4, 2012, Pages 420-425

  Daher, E F ^a   Silva Jr , G B ^a,b   De Abreu, K L S ^a   Mota, R M S ^a   Batista, D V ^a   Rocha, N A ^a   Araujo S M H A ^a   Liborio A B ^b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF FORTALEZA   (Brazil)

Author keywords

leptospirosis; mortality; outcome; penicillin; treatment; Weil's disease

Indexed keywords

PENICILLIN G;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BRAZIL; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LEPTOSPIROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAZIL; CHILD; FEMALE; HUMANS; LENGTH OF STAY; LEPTOSPIROSIS; MALE; MIDDLE AGED; PENICILLINS; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84863493158     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2011.01312.x     Document Type: Article

References (24)

1. Adler B, de la Peña Moctezuma A,. Leptospira and leptospirosis. Vet Microbiol, 2010; 140: 287-296.
2. Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis, 2003; 3: 757-771. (Pubitemid 37489960)
3. Griffith ME, Hospenthal DR, Murray CK,. Antimicrobial therapy of leptospirosis. Curr Opin Infect Dis, 2006; 19: 533-537. (Pubitemid 44665458)
4. Daher EF, Nogueira CB,. Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure. Rev Inst Med Trop Sao Paulo, 2000; 42: 327-332. (Pubitemid 32057364)
5. Michalopoulos A, Pappas G, Papadakis E, Chirtoforatos T, Malamos P, Koumoudiou C, Chalevelakis G,. Leptospirosis in a European intensive care unit. Scand J Infect Dis, 2010; 42: 69-71.
6. Shah I,. Non-oliguric renal failure-a presentation of leptospirosis. Ann Trop Med Parasitol, 2009; 103: 53-56.
7. Cerqueira TB, Athanazio DA, Spichler AS, Seguro AC,. Renal involvement in leptospirosis-new insights into pathophysiology and treatment. Braz J Infect Dis, 2008; 12: 248-252.
8. Spichler A, Ko AI, Silva EF, et al. Reversal of renal tubule transporter down-regulation during severe leptospirosis with antimicrobial therapy. Am J Trop Med Hyg, 2007; 77: 1111-1119. (Pubitemid 351837803)
9. Guidugli F, Castro AA, Atallah AN, Araújo MG,. Antibiotics for treating leptospirosis. Cochrane Database Syst Rev, 2010; 20: CD001306.
10. Ricci Z, Cruz D, Ronco C,. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int, 2008; 73: 538-546. (Pubitemid 351264114)
11. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A,. Acute kidney injury network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Critical Care, 2007; 11: R31.
12. Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W,. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis, 2003; 36: 1507-1513. (Pubitemid 36783331)
13. Raptis L, Pappas G, Akritidis N,. Use of ceftriaxone in patients with severe leptospirosis. Int J Antimicrob Agents, 2006; 28: 259-261. (Pubitemid 44223985)
14. Ressner RA, Griffith ME, Beckius ML, et al. Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. Antimicrob Agents Chemother, 2008; 52: 2750-2754.
15. Ziegeler S, Raddatz A, Hoff G, et al. Antibiotics modulate the stimulated cytokine response to endotoxin in a human ex vivo, in vitro model. Acta Anaesthesiol Scand, 2006; 50: 1103-1110. (Pubitemid 44434749)
16. Habib M,. La découverte de la penicillin: une revolution dans le traitment de la syphilis. Tunis Med, 2009; 87: 369-371.
17. Mandell GL, Bennett JE, Dolin R,. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 7th edn. London: Churchill Livingstone, 2009.
18. Silva R, Cruz L, Botelho C, Castro E, Cadinha S, Castel-Branco MG, Rodrigues J,. Immediate hypersensitivity to penicillins with negative skin tests-the value of specific IgE. Eur Ann Allergy Clin Immunol, 2009; 41: 117-119.
19. Qiao HL, Li Z, Yang J, Tian X, Gao N, Jia LJ,. Hypersensitivity reactions to penicillins: studies in a group of patients with negative benzylpenicillin G skin test. J Clin Pharm Ther, 2009; 34: 249-254.
20. Watt G, Padre LP, Tuazon ML, Calubaquib C, Santiago E, Ranoa CP, Laughlin LW,. Palcebo controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet, 1988; 1: 433-435. (Pubitemid 18067676)
21. Costa E, Lopes AA, Sacramento E, Costa YA, Matos ED, Lopes MB, Bina JC,. Penicillin at the late stage of leptospirosis: a randomized controlled trial. Rev Inst Med Trop Sao Paulo, 2003; 45: 141-145. (Pubitemid 36876483)
22. Conti E, Lazzarini L, Reatto P, Tositti G, de Lalla F,. Human leptospirosis in the Vicenza area (Italy) from 1990 to 2003: an epidemiological and clinical study. Infez Med, 2005; 13: 235-240. (Pubitemid 43242008)
23. Cetin BD, Harmankaya O, Hasman H, Gunduz A, Okar M, Seber E,. Acute renal failure: a common manifestation of leptospirosis. Ren Fail, 2004; 26: 655-661. (Pubitemid 39579127)
24. Andrade L, Cleto S, Seguro AC,. Door-todialysis time and daily hemodialysis in patients with leptospirosis: impact on mortality. Clin J Am Soc Nephrol, 2007; 2: 739-744.